Pathologist Dr. Elizabeth Hammond, from Intermountain Healthcare, Discusses the Ongoing ASCO/CAP HER2 Testing Guideline Revisions.
M. Elizabeth Hammond, MD
Advertisement
Articles by M. Elizabeth Hammond, MD
Advertisement
Latest Updated Articles
Dr. Hammond Discusses HER2 Testing Guideline RevisionsSeptember 20th 2012
Advertisement
Advertisement
Trending on OncLive
1
Broadening HER2-Mutated NSCLC Data Support First-Line Zongertinib Followed by T-DXd
2
Subcutaneous Toripalimab Plus Disitamab Vedotin sNDA Is Accepted in China for HER2-Expressing Urothelial Cancer
3
A New Era in Pancreatic Cancer Treatment: Daraxonrasib Shakes Up the Landscape
4
Combining 2 VEGF-Blocking Targeted Therapies Significantly Boosted Survival in Kidney Cancer Study
5